{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T15:34:49Z","timestamp":1770478489072,"version":"3.49.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"S3","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Neurosci"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1186\/1471-2202-9-s3-s3","type":"journal-article","created":{"date-parts":[[2008,12,10]],"date-time":"2008-12-10T19:12:45Z","timestamp":1228936365000},"source":"Crossref","is-referenced-by-count":48,"title":["NAP and D-SAL: neuroprotection against the \u03b2 amyloid peptide (1\u201342)"],"prefix":"10.1186","volume":"9","author":[{"given":"Illana","family":"Gozes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inna","family":"Divinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inbar","family":"Piltzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,12,10]]},"reference":[{"key":"1000_CR1","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1046\/j.1471-4159.1999.0721283.x","volume":"72","author":"M Bassan","year":"1999","unstructured":"Bassan M, Zamostiano R, Davidson A, Pinhasov A, Giladi E, Perl O, Bassan H, Blat C, Gibney G, Glazner G, Brenneman DE, Gozes I: Complete sequence of a novel protein containing a femtomolar-activity-dependent neuroprotective peptide. J Neurochem. 1999, 72: 1283-1293. 10.1046\/j.1471-4159.1999.0721283.x.","journal-title":"J Neurochem"},{"key":"1000_CR2","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.pharmthera.2007.01.004","volume":"114","author":"I Gozes","year":"2007","unstructured":"Gozes I: Activity-dependent neuroprotective protein: from gene to drug candidate. Pharmacol Ther. 2007, 114: 146-154. 10.1016\/j.pharmthera.2007.01.004.","journal-title":"Pharmacol Ther"},{"key":"1000_CR3","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0165-3806(03)00162-7","volume":"144","author":"A Pinhasov","year":"2003","unstructured":"Pinhasov A, Mandel S, Torchinsky A, Giladi E, Pittel Z, Goldsweig AM, Servoss SJ, Brenneman DE, Gozes I: Activity-dependent neuroprotective protein: a novel gene essential for brain formation. Brain Res Dev Brain Res. 2003, 144: 83-90. 10.1016\/S0165-3806(03)00162-7.","journal-title":"Brain Res Dev Brain Res"},{"key":"1000_CR4","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.ydbio.2006.11.039","volume":"303","author":"S Mandel","year":"2007","unstructured":"Mandel S, Rechavi G, Gozes I: Activity-dependent neuroprotective protein (ADNP) differentially interacts with chromatin to regulate genes essential for embryogenesis. Dev Biol. 2007, 303: 814-824. 10.1016\/j.ydbio.2006.11.039.","journal-title":"Dev Biol"},{"key":"1000_CR5","doi-asserted-by":"publisher","first-page":"34448","DOI":"10.1074\/jbc.M704756200","volume":"282","author":"S Mandel","year":"2007","unstructured":"Mandel S, Gozes I: Activity-dependent neuroprotective protein constitutes a novel element in the SWI\/SNF chromatin remodeling complex. J Biol Chem. 2007, 282: 34448-34456. 10.1074\/jbc.M704756200.","journal-title":"J Biol Chem"},{"key":"1000_CR6","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.mce.2006.03.029","volume":"252","author":"RA Steingart","year":"2006","unstructured":"Steingart RA, Gozes I: Recombinant activity-dependent neuroprotective protein protects cells against oxidative stress. Mol Cell Endocrinol. 2006, 252: 148-153. 10.1016\/j.mce.2006.03.029.","journal-title":"Mol Cell Endocrinol"},{"key":"1000_CR7","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1017\/S1740925X05000013","volume":"1","author":"S Furman","year":"2004","unstructured":"Furman S, Steingart RA, Mandel S, Hauser JM, Brenneman DE, Gozes I: Subcellular localization and secretion of activity-dependent neuroprotective protein in astrocytes. Neuron Glia Biol. 2004, 1: 193-199. 10.1017\/S1740925X05000013.","journal-title":"Neuron Glia Biol"},{"key":"1000_CR8","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0165-3806(96)00215-5","volume":"99","author":"I Gozes","year":"1997","unstructured":"Gozes I, Davidson A, Gozes Y, Mascolo R, Barth R, Warren D, Hauser J, Brenneman DE: Antiserum to activity-dependent neurotrophic factor produces neuronal cell death in CNS cultures: immunological and biological specificity. Brain Res Dev Brain Res. 1997, 99: 167-175. 10.1016\/S0165-3806(96)00215-5.","journal-title":"Brain Res Dev Brain Res"},{"key":"1000_CR9","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1172\/JCI118672","volume":"97","author":"DE Brenneman","year":"1996","unstructured":"Brenneman DE, Gozes I: A femtomolar-acting neuroprotective peptide. J Clin Invest. 1996, 97: 2299-2307. 10.1172\/JCI118672.","journal-title":"J Clin Invest"},{"key":"1000_CR10","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/BF02737061","volume":"7","author":"I Gozes","year":"1996","unstructured":"Gozes I, Brenneman DE: Activity-dependent neurotrophic factor (ADNF). An extracellular neuroprotective chaperonin?. J Mol Neurosci. 1996, 7: 235-244. 10.1007\/BF02737061.","journal-title":"J Mol Neurosci"},{"key":"1000_CR11","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1017\/CBO9780511546310.016","volume-title":"Molecular Chaperones and Cell Signalling","author":"I Gozes","year":"2005","unstructured":"Gozes I, Vulih I, Spivak-Pohis I, Furman S: Neuroendocrine aspects of the molecular chapernoes ADNF and ADNP. Molecular Chaperones and Cell Signalling. Edited by: Henderson B, Pockley AG. 2005, Cambridge, UK: Cambridge University Press, 251-262."},{"key":"1000_CR12","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1749-6632.1999.tb07884.x","volume":"897","author":"I Gozes","year":"1999","unstructured":"Gozes I, Bassan M, Zamostiano R, Pinhasov A, Davidson A, Giladi E, Perl O, Glazner GW, Brenneman DE: A novel signaling molecule for neuropeptide action: activity-dependent neuroprotective protein. Ann N Y Acad Sci. 1999, 897: 125-135. 10.1111\/j.1749-6632.1999.tb07884.x.","journal-title":"Ann N Y Acad Sci"},{"key":"1000_CR13","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0022-3565(24)37441-5","volume":"285","author":"DE Brenneman","year":"1998","unstructured":"Brenneman DE, Hauser J, Neale E, Rubinraut S, Fridkin M, Davidson A, Gozes I: Activity-dependent neurotrophic factor: structure-activity relationships of femtomolar-acting peptides. J Pharmacol Exp Ther. 1998, 285: 619-627.","journal-title":"J Pharmacol Exp Ther"},{"key":"1000_CR14","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/j.1527-3458.2005.tb00053.x","volume":"11","author":"I Gozes","year":"2005","unstructured":"Gozes I, Morimoto BH, Tiong J, Fox A, Sutherland K, Dangoor D, Holser-Cochav M, Vered K, Newton P, Aisen PS, Matsuoka Y, van Dyck CH, Thal L: NAP: research and development of a peptide derived from activity-dependent neuroprotective protein (ADNP). CNS Drug Rev. 2005, 11: 353-368.","journal-title":"CNS Drug Rev"},{"key":"1000_CR15","doi-asserted-by":"publisher","first-page":"197","DOI":"10.2174\/156720506777632790","volume":"3","author":"I Gozes","year":"2006","unstructured":"Gozes I, Spivak-Pohis I: Neurotrophic effects of the peptide NAP: a novel neuroprotective drug candidate. Curr Alzheimer Res. 2006, 3: 197-199. 10.2174\/156720506777632790.","journal-title":"Curr Alzheimer Res"},{"key":"1000_CR16","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1124\/jpet.106.106898","volume":"319","author":"M Rotstein","year":"2006","unstructured":"Rotstein M, Bassan H, Kariv N, Speiser Z, Harel S, Gozes I: NAP enhances neurodevelopment of newborn apolipoprotein E-deficient mice subjected to hypoxia. J Pharmacol Exp Ther. 2006, 319: 332-339. 10.1124\/jpet.106.106898.","journal-title":"J Pharmacol Exp Ther"},{"key":"1000_CR17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0167-0115(00)00198-1","volume":"96","author":"I Zemlyak","year":"2000","unstructured":"Zemlyak I, Furman S, Brenneman DE, Gozes I: A novel peptide prevents death in enriched neuronal cultures. Regul Pept. 2000, 96: 39-43. 10.1016\/S0167-0115(00)00198-1.","journal-title":"Regul Pept"},{"key":"1000_CR18","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/j.peptides.2003.08.005","volume":"24","author":"O Ashur-Fabian","year":"2003","unstructured":"Ashur-Fabian O, Segal-Ruder Y, Skutelsky E, Brenneman DE, Steingart RA, Giladi E, Gozes I: The neuroprotective peptide NAP inhibits the aggregation of the beta-amyloid peptide. Peptides. 2003, 24: 1413-1423. 10.1016\/j.peptides.2003.08.005.","journal-title":"Peptides"},{"key":"1000_CR19","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/j.1471-4159.2004.02513.x","volume":"90","author":"Y Hashimoto","year":"2004","unstructured":"Hashimoto Y, Kaneko Y, Tsukamoto E, Frankowski H, Kouyama K, Kita Y, Niikura T, Aiso S, Bredesen DE, Matsuoka M, Nishimoto I: Molecular characterization of neurohybrid cell death induced by Alzheimer's amyloid-beta peptides via p75NTR\/PLAIDD. J Neurochem. 2004, 90: 549-558. 10.1111\/j.1471-4159.2004.02513.x.","journal-title":"J Neurochem"},{"key":"1000_CR20","doi-asserted-by":"publisher","first-page":"4125","DOI":"10.1073\/pnas.96.7.4125","volume":"96","author":"Q Guo","year":"1999","unstructured":"Guo Q, Sebastian L, Sopher BL, Miller MW, Glazner GW, Ware CB, Martin GM, Mattson MP: Neurotrophic factors [activity-dependent neurotrophic factor (ADNF) and basic fibroblast growth factor (bFGF)] interrupt excitotoxic neurodegenerative cascades promoted by a PS1 mutation. Proc Natl Acad Sci USA. 1999, 96: 4125-4130. 10.1073\/pnas.96.7.4125.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1000_CR21","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1124\/jpet.103.063891","volume":"309","author":"DE Brenneman","year":"2004","unstructured":"Brenneman DE, Spong CY, Hauser JM, Abebe D, Pinhasov A, Golian T, Gozes I: Protective peptides that are orally active and mechanistically nonchiral. J Pharmacol Exp Ther. 2004, 309: 1190-1197. 10.1124\/jpet.103.063891.","journal-title":"J Pharmacol Exp Ther"},{"key":"1000_CR22","doi-asserted-by":"publisher","first-page":"3592","DOI":"10.1523\/JNEUROSCI.5167-03.2004","volume":"24","author":"RH Takahashi","year":"2004","unstructured":"Takahashi RH, Almeida CG, Kearney PF, Yu F, Lin MT, Milner TA, Gouras GK: Oligomerization of Alzheimer's beta-amyloid within processes and synapses of cultured neurons and brain. J Neurosci. 2004, 24: 3592-3599. 10.1523\/JNEUROSCI.5167-03.2004.","journal-title":"J Neurosci"},{"key":"1000_CR23","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","volume":"39","author":"S Oddo","year":"2003","unstructured":"Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM: Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron. 2003, 39: 409-421. 10.1016\/S0896-6273(03)00434-3.","journal-title":"Neuron"},{"key":"1000_CR24","doi-asserted-by":"publisher","first-page":"28531","DOI":"10.1074\/jbc.M403197200","volume":"279","author":"I Divinski","year":"2004","unstructured":"Divinski I, Mittelman L, Gozes I: A femtomolar acting octapeptide interacts with tubulin and protects astrocytes against zinc intoxication. J Biol Chem. 2004, 279: 28531-28538. 10.1074\/jbc.M403197200.","journal-title":"J Biol Chem"},{"key":"1000_CR25","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1385\/JMN:28:3:303","volume":"28","author":"M Holtser-Cochav","year":"2006","unstructured":"Holtser-Cochav M, Divinski I, Gozes I: Tubulin is the target binding site for NAP-related peptides: ADNF-9, D-NAP, and D-SAL. J Mol Neurosci. 2006, 28: 303-307. 10.1385\/JMN:28:3:303.","journal-title":"J Mol Neurosci"},{"key":"1000_CR26","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1111\/j.1471-4159.2006.03936.x","volume":"98","author":"I Divinski","year":"2006","unstructured":"Divinski I, Holtser-Cochav M, Vulih-Schultzman I, Steingart RA, Gozes I: Peptide neuroprotection through specific interaction with brain tubulin. J Neurochem. 2006, 98: 973-984. 10.1111\/j.1471-4159.2006.03936.x.","journal-title":"J Neurochem"},{"key":"1000_CR27","doi-asserted-by":"publisher","first-page":"507","DOI":"10.2174\/156720507783018208","volume":"4","author":"I Gozes","year":"2007","unstructured":"Gozes I, Divinski I: NAP, a neuroprotective drug candidate in clinical trials, stimulates microtubule assembly in the living cell. Curr Alzheimer Res. 2007, 4: 507-509. 10.2174\/156720507783018208.","journal-title":"Curr Alzheimer Res"},{"issue":"suppl","key":"1000_CR28","first-page":"S37","volume":"6","author":"I Gozes","year":"2004","unstructured":"Gozes I, Divinski I: The femtomolar-acting NAP interacts with microtubules: Novel aspects of astrocyte protection. J Alzheimers Dis. 2004, 6 (suppl): S37-S41.","journal-title":"J Alzheimers Dis"},{"key":"1000_CR29","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1124\/jpet.107.130526","volume":"325","author":"Y Matsuoka","year":"2008","unstructured":"Matsuoka Y, Jouroukhin Y, Gray AJ, Ma L, Hirata-Fukae C, Li HF, Feng L, Lecanu L, Walker BR, Planel E, Arancio O, Gozes I, Aisen PS: A neuronal microtubule-interacting agent, NAPVSIPQ, reduces tau pathology and enhances cognitive function in a mouse model of Alzheimer's disease. J Pharmacol Exp Ther. 2008, 325: 146-153. 10.1016\/j.jalz.2006.05.2074.","journal-title":"J Pharmacol Exp Ther"},{"key":"1000_CR30","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/276411a0","volume":"276","author":"I Gozes","year":"1978","unstructured":"Gozes I, Littauer UZ: Tubulin microheterogeneity increases with rat brain maturation. Nature. 1978, 276: 411-413. 10.1038\/276411a0.","journal-title":"Nature"},{"key":"1000_CR31","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/294477a0","volume":"294","author":"I Gozes","year":"1981","unstructured":"Gozes I, Sweadner KJ: Multiple tubulin forms are expressed by a single neurone. Nature. 1981, 294: 477-480. 10.1038\/294477a0.","journal-title":"Nature"},{"key":"1000_CR32","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1073\/pnas.79.8.2579","volume":"79","author":"I Gozes","year":"1982","unstructured":"Gozes I, Barnstable CJ: Monoclonal antibodies that recognize discrete forms of tubulin. Proc Natl Acad Sci USA. 1982, 79: 2579-2583. 10.1073\/pnas.79.8.2579.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1000_CR33","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S0022-3565(24)39336-X","volume":"293","author":"I Gozes","year":"2000","unstructured":"Gozes I, Giladi E, Pinhasov A, Bardea A, Brenneman DE: Activity-dependent neurotrophic factor: intranasal administration of femtomolar-acting peptides improve performance in a water maze. J Pharmacol Exp Ther. 2000, 293: 1091-1098.","journal-title":"J Pharmacol Exp Ther"},{"key":"1000_CR34","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1161\/01.STR.0000014207.05597.D7","volume":"33","author":"RR Leker","year":"2002","unstructured":"Leker RR, Teichner A, Grigoriadis N, Ovadia H, Brenneman DE, Fridkin M, Giladi E, Romano J, Gozes I: NAP, a femtomolar-acting peptide, protects the brain against ischemic injury by reducing apoptotic death. Stroke. 2002, 33: 1085-1092. 10.1161\/01.STR.0000014207.05597.D7.","journal-title":"Stroke"},{"issue":"suppl 2","key":"1000_CR35","first-page":"213","volume":"38","author":"BH Morimoto","year":"2006","unstructured":"Morimoto BH, de Lannoy I, Liu X, Gien B, Yang Y, Fox A, Tiong J, Gozes I: Pharmacokinetics of the neuroprotective peptide, NAPVSIPQ in serial samples of plasma and CSF after intravenous or intranasal administration. Drug Metab Rev. 2006, 38 (suppl 2): 213-214.","journal-title":"Drug Metab Rev"},{"key":"1000_CR36","unstructured":"Allon Therapeutics Inc. [ http:\/\/www.allontherapeutics.com ]"}],"container-title":["BMC Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2202-9-S3-S3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2202-9-S3-S3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2202-9-S3-S3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T03:45:30Z","timestamp":1738813530000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurosci.biomedcentral.com\/articles\/10.1186\/1471-2202-9-S3-S3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":36,"journal-issue":{"issue":"S3","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["1000"],"URL":"https:\/\/doi.org\/10.1186\/1471-2202-9-s3-s3","relation":{},"ISSN":["1471-2202"],"issn-type":[{"value":"1471-2202","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12]]},"article-number":"S3"}}